Cart

“Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Product	Price	Quantity	Subtotal
×	Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder PDF	$40.00	Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder PDF quantity	$40.00
×	Concise Associated Symptoms Tracking Scale: A Brief Self-Report and Clinician Rating of Symptoms Associated With Suicidality PDF	$40.00	Concise Associated Symptoms Tracking Scale: A Brief Self-Report and Clinician Rating of Symptoms Associated With Suicidality PDF quantity	$40.00
×	Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial PDF	$40.00	Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial PDF quantity	$40.00
×	The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder: A Randomized Trial PDF	$40.00	The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder: A Randomized Trial PDF quantity	$40.00
×	The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF	$40.00	The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF quantity	$40.00
×	Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder? A STAR*D Report PDF	$40.00	Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder? A STAR*D Report PDF quantity	$40.00
×	Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit/Hyperactivity Disorder PDF	$40.00	Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit/Hyperactivity Disorder PDF quantity	$40.00
×	Effect of Antidepressant Medication Treatment on Suicidal Ideation and Behavior in a Randomized Trial: An Exploratory Report From the Combining Medications to Enhance Depression Outcomes Study PDF	$40.00	Effect of Antidepressant Medication Treatment on Suicidal Ideation and Behavior in a Randomized Trial: An Exploratory Report From the Combining Medications to Enhance Depression Outcomes Study PDF quantity	$40.00
×	Epidemiology of Major Depression With Atypical Features: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF	$40.00	Epidemiology of Major Depression With Atypical Features: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF quantity	$40.00
×	Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial PDF	$40.00	Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial PDF quantity	$40.00
×	A Case-Controlled Study of Successful Aging in Older HIV-Infected Adults PDF	$40.00	A Case-Controlled Study of Successful Aging in Older HIV-Infected Adults PDF quantity	$40.00
×	Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report PDF	$40.00	Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report PDF quantity	$40.00
×	Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study PDF	$40.00	Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study PDF quantity	$40.00
×	Catatonia in the Setting of Hyponatremia PDF	$40.00	Catatonia in the Setting of Hyponatremia PDF quantity	$40.00
×	Reconceptualizing Medication Management: Implications for Training and Clinical Practice PDF	$40.00	Reconceptualizing Medication Management: Implications for Training and Clinical Practice PDF quantity	$40.00
×	Is DSM-IV Bereavement Exclusion for Major Depression Relevant to Treatment Response? A Case-Control, Prospective Study PDF	$40.00	Is DSM-IV Bereavement Exclusion for Major Depression Relevant to Treatment Response? A Case-Control, Prospective Study PDF quantity	$40.00
×	Prescribing Patterns in a Psychiatrically Referred Sample of Youth With Autism Spectrum Disorder PDF	$40.00	Prescribing Patterns in a Psychiatrically Referred Sample of Youth With Autism Spectrum Disorder PDF quantity	$40.00
×	Medication Continuation and Compliance: A Comparison of Patients Treated With Clozapine and Haloperidol PDF	$40.00	Medication Continuation and Compliance: A Comparison of Patients Treated With Clozapine and Haloperidol PDF quantity	$40.00
×	Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes PDF	$40.00	Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes PDF quantity	$40.00
×	A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder PDF	$40.00	A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder PDF quantity	$40.00
×	A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder PDF	$40.00	A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder PDF quantity	$40.00
×	The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies PDF	$40.00	The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies PDF quantity	$40.00
×	A Multisite Study of Initial Respiration Rate and Heart Rate as Predictors of Posttraumatic Stress Disorder PDF	$40.00	A Multisite Study of Initial Respiration Rate and Heart Rate as Predictors of Posttraumatic Stress Disorder PDF quantity	$40.00
×	Response to Missile Attacks on Civilian Targets in Patients With Panic Disorder. PDF	$40.00	Response to Missile Attacks on Civilian Targets in Patients With Panic Disorder. PDF quantity	$40.00
×	Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study PDF	$40.00	Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Join Now

Cart totals

Subtotal	$1,000.00
Total	$1,000.00

Proceed to checkout

Cart

Cart totals

ELSEWHERE:

FOLLOW US:

Cart

Cart totals

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles